Voyager Therapeutics Inc.

(VYGR) Trade

By |

Profile

Voyager Therapeutics Inc in collaboration with Genzyme, conducts research and development work to develop therapies for the treatment of central nervous system disorders. It targets diseases such as Parkinson's, Alzheimer's Huntington's.

Contact Information

Website: www.voyagertherapeutics.com
Email: sarah@sternir.com
Main Phone: +1 857 259-5340
Address: 75 Sidney Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Steven M. Paul
Employees: 88
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 22.50 $ 1.33 (6.28%)
Last Price 22.50 Change $ 1.33 Change % 6.28 Tick N/A
Bid 22.00 Bid Size 1,000.00 Ask 22.50 Ask Size 200.00
Open 23.00 High 23.89 Low 21.16 Prev Close 21.17
Last Trade Volume 1.7 mi 52 Wk Hi 31.91 52 Wk Low 8.10
Market Cap 727.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,320,996.00 EPS (TTM) -2.62 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 9 23
Number of Buys 4 4
Number of Sells 5 19
Net Activity -2451 -86149
Last 10 Buys Shares
Steven M. Paul 1,000
Last 10 Sell Shares
Bernard Ravina 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Jane Pritchett Henderson 1,000
Bernard Ravina 1,000
Dinah Sah 1,000
Bernard Ravina 1,000
Bernard Ravina 1,000
Bernard Ravina 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 43 43 43 43
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 32.22 32.5 32.5 32.22
Standard Deviation 7.36 7.82 7.82 7.36
Date of Most Recent Estimate 06/04/18 05/16/18 05/16/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 2 2 2 2
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.63 1.63